Our Ideas - Pharma

These are the posts from the Our Ideas section that have been tagged with Pharma.

To see all tags used in our posts, click here.

intro-to-manufacturing-biologics-lab-science

Introduction to the manufacturing of biologics

Ditte Funding | 12th December 2016

The last decade has seen the rapid growth of biologics in the pharma market, making them a key sector to watch. With their growing popularity, it’s important to understand the opportunities and threats they present. Associate Consultant Ditte Funding takes us through how biologics are made, what makes them unique, and what it all means for pharma companies.

read more

patient-perspective-living-with-crohns-disease-blue-latitude-health

Living with Crohn's disease: a patient perspective

Victoria Morton | 16th November 2016

Account Executive Victoria Morton explores what it’s like to live with Crohn’s disease as a young person, and investigates what’s being done to tackle the gaps in treatment options for patients.

read more

compass-hand-sea-navigation-guidance-photograph

Are reverse auctions the best way to procure marketing services?

Martin Brass | 6th October 2016

Managing Director Martin Brass discusses what a reverse auction is, and whether it truly is a good way for healthcare companies to drive efficiencies when procuring marketing services.

read more

photo-sad-man-powder-face

Are we harnessing the full emotional power of brand creativity?

Damien Parsonage | 30th September 2016

Creative Director Damien Parsonage breaks down the common misconception that pharma and healthcare marketing for healthcare professionals ought to be entirely scientific and rational. Brands are powerful; here's how to strengthen yours by infusing it with emotion.

read more

chessboard-strategy-photo

Marketing strategy in complex environments

Mark Assenti, Kulveer Singh | 19th September 2016

Age-old treatment protocols are being replaced with new and innovative treatment paradigms that will revolutionise the healthcare industry for years to come. Kulveer Singh and Mark Assenti talk through what this means for pharma strategists and their product lines.

read more

library-card-file-stock-photograph_DAM-vs-CMS-pharma-content-management

DAM and CMS: managing assets to maximise adoption and value

David Wood | 14th September 2016

Senior Account Executive Dave Wood talks us through what DAM and CMS are, the role they play in the future of healthcare marketing, and how they can be best utilised to maximise outcomes for pharma and agencies.

read more

Alzheimer's Disease eeviewing the immediate treatment horizon

Alzheimer’s disease: reviewing the immediate treatment horizon

Stuart Goodman | 2nd September 2016

Account Manager Stuart Goodman takes a look at some of the promising categories of Phase 3 treatments that could soon be available to patients with Alzheimer's disease.

read more

Stumble-but-not-a-fall-whats-next-for-opdivo-feature-image

A stumble, but not a fall – what’s next for Opdivo?

Louis Perdios | 24th August 2016

In this article, Associate Consultant Louis Perdios talks about the immunotherapy drug Opdivo and the daunting challenges faced by BMS after disappointing results. However the future for Opdivo may not be as bleak as it seems. 

 

read more

doctor-macro-health-Blue_Latitude_Health

Immuno-oncology; bringing patients closer to treatment

Frances Hendry, Zoe Bartley | 18th August 2016

What do the new immunotherapies in oncology mean for those stakeholders who need to understand and make decisions about treatment? Even more importantly, what do immunotherapies mean for patients who face diagnosis of advanced cancers? Senior Associate Consultants Frances Hendry and Zoe Bartley tackle these complex questions.

read more

Plagiomnium_affine_laminazellen_cells

The biofuel cell – breathing new life into portable electronics?

Kulveer Singh | 16th August 2016

Associate Medical Copywriter Kulveer Singh explains how biofuel cells work, why they are an exciting alternative to normal battery power, and what the challenges are in implementing their use.

read more